Products
17036 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Newmont Constant Leverage with ISIN code: CH1290992911 | Newmont | Constant Leverage | Long | ― | 53.393 | 44.44 | 0.130 | 44.57 | 1 | -0.29 % | 14.21 % | 42.94 % | 16 Feb. 2024 | |
Nike Constant Leverage with ISIN code: CH1362349826 | Nike | Constant Leverage | Long | ― | 83.33 | 14.53 | 0.090 | 14.62 | 1 | -0.62 % | -7.69 % | 57.08 % | 9 Jul. 2024 | |
Nike Constant Leverage with ISIN code: CH1119067986 | Nike | Constant Leverage | Long | ― | 83.33 | 0.19 | 0.010 | 0.2 | 1 | -5.00 % | -9.52 % | 26.67 % | 12 May. 2022 | |
Nike Constant Leverage with ISIN code: CH1362349834 | Nike | Constant Leverage | Long | ― | 83.33 | 15.69 | 0.120 | 15.81 | 1 | -0.76 % | -11.10 % | 73.75 % | 9 Jul. 2024 | |
Nike Constant Leverage with ISIN code: CH1362350402 | Nike | Constant Leverage | Long | ― | 83.33 | 12.76 | 0.050 | 12.81 | 1 | -0.39 % | -4.56 % | ― | 12 Aug. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 4.007 | 0.31 | 0.030 | 0.34 | 1 | -8.82 % | 29.17 % | 40.91 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 4.007 | 1.07 | 0.030 | 1.1 | 1 | -2.73 % | 24.42 % | 35.44 % | 6 May. 2022 | |
Novartis Constant Leverage with ISIN code: CH1346746238 | Novartis | Constant Leverage | Long | ― | 102.12 | 15.55 | 0.050 | 15.6 | 1 | -0.32 % | 6.87 % | 11.87 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746246 | Novartis | Constant Leverage | Long | ― | 102.12 | 18.1 | 0.100 | 18.2 | 1 | -0.55 % | 10.37 % | 15.65 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746253 | Novartis | Constant Leverage | Long | ― | 102.12 | 20.25 | 0.150 | 20.4 | 1 | -0.74 % | 13.76 % | 18.08 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 102.12 | 14.22 | ― | ― | 1 | 0.00 % | 7.65 % | 14.03 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 102.12 | 10.86 | ― | ― | 1 | 0.00 % | 20.13 % | 25.40 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 102.12 | 14.48 | ― | ― | 1 | 0.00 % | 11.73 % | 19.37 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 102.12 | 13.27 | ― | ― | 1 | 0.00 % | 15.90 % | 23.33 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 20.56 | 0.230 | 20.79 | 1 | -1.11 % | 8.90 % | -3.56 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587347 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 16.45 | 0.270 | 16.72 | 1 | -1.61 % | 13.60 % | -15.94 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 8.58 | 0.100 | 8.68 | 1 | -1.15 % | 8.75 % | -3.70 % | 9 Jul. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 6.98 | 0.110 | 7.09 | 1 | -1.55 % | 13.68 % | -16.00 % | 11 Mar. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 0.19 | 0.030 | 0.22 | 1 | -13.64 % | 11.76 % | -91.70 % | 23 Feb. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993026 | Novo Nordisk | Constant Leverage | Long | ― | 938.516 | 4.76 | 0.100 | 4.86 | 1 | -2.06 % | 18.11 % | -33.98 % | 23 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.